MedTrace Logo

Staging Candidiasis in ICU Patients

NCT01322698 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 422

Last updated 2025-11-17

No results posted yet for this study

Summary

Our primary objective is to evaluate the relevance of the early determination of Candida infection status among non-neutropenic patients hospitalized over 48 hours in ICUs.

Conditions

  • Candidiasis

Interventions

BIOLOGICAL

Tests for candidiasis

Tests include (1) anti-candida antibody ELISA kit; (2) candida antigen ELISA kit; (3) detection of circulating Candida DNA via SYBR Breen qPCR Master mix; (4) colonization index based on mycological examination of five out of the following: urine, oral swab, bronchial aspirate, anal swab, swab of a central venous line, gastric liquid.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Laurence Lachaud, MD · Centre Hospitalier Universitaire de Nîmes

  • Nathalie Bourgeois, MD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-10-07
Completion
2014-10-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01322698 on ClinicalTrials.gov